Therapeutic Goods (Listing) Notice 2002 (No. 6)

Published in the Commonwealth of Australia Gazette No. GN 41, 16 October 2002

Therapeutic Goods Act 1989

I, TERRY SLATER, National Manager, Therapeutic Goods Administration, delegate of the Parliamentary Secretary to the Minister for Health and Ageing, under subsection 17 (5) of the Therapeutic Goods Act 1989, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods for listed goods:

1. preparations, referred to in item 3 of Schedule 4, Part 1 of the Regulations that contain, as active ingredients, boric acid, borax, sodium perborate and borax pentahydrate, which are to be mentioned in Part 3 of Schedule 4 of the Regulations, in which the boron amounts are limited to those below amounts included on the Standard for the Uniform Scheduling of Drugs and Poisons (SUSDP). The limitation on the boron content in preparations is to be mentioned in Division 2, Subdivision 2 of Part 5 of the Regulations.
2. preparations, referred to in item 3 of Schedule 4, Part 1 of the Therapeutic Goods Regulations (the Regulations) that contain, as an active ingredient, molybdenum trioxide, which is to be mentioned in Part 3 of Schedule 4 of the Regulations, in which the recommended daily dose of molybdenum does not exceed 125 micrograms/day (corresponding to 187.54 micrograms/day of the trioxide). The limitation on the daily dose of molybdenum is to be mentioned in Division 2, Subdivision 2 of Part 5 of the Regulations.
3. preparations, referred to in item 3 of Schedule 4, Part 1 the Regulations that contain, as an active ingredient, magnesium phosphate dibasic trihydrate, which is to be mentioned in Part 3 of Schedule 4 of the Regulations.

Dated 9 October 2002

National Manager, Therapeutic Goods Administration
Delegate of the Parliamentary Secretary